ÂÜÀòÂÒÂ×

Jeymi Tambiah currently serves as Chief Medical Officer at Genascence Corporation since October 2024. Prior to this role, Jeymi held various senior positions at Biosplice Therapeutics from April 2021 to October 2024, including SVP Clinical Development and External Innovation and Senior VP Medical Affairs. Jeymi's experience also encompasses a Senior VP Medical Affairs role at Samumed from March 2018 to April 2021, and earlier positions in Medical Affairs at UCB, where responsibilities included Medical Director for US Medical Affairs in Immunology. Jeymi's clinical foundation was established at Guys' and St Thomas' NHS Foundation Trust as a Specialist Registrar in Cardiothoracic Surgery. Educational qualifications include a Doctorate degree in Immunology and Atherosclerosis from Imperial College London and multiple fellowships and degrees in Medicine and Pharmaceutical Medicine from prestigious institutions.